Manfredi Lefebvre d'Ovidio, a director at Arqit Quantum Inc., reported a transaction on July 17, 2026. The transaction involved the acquisition of 673 Ordinary Shares with a price of $0.0 per share. Following this transaction, the post-transaction shares owned are 49,023. Additionally, 673 Restricted Share Units (RSUs)...

On July 20, 2026, James C. Leonard, EVP & Chief Operating Officer of Fifth Third Bancorp, exercised stock appreciation rights (SARs) from four different grants and sold the underlying common stock. The transactions involved exercising SARs covering 31,639 shares at exercise prices ranging from $26.52 to $33.17 per shar...

On July 8, 2026, Frank Hurst Lin reported a transaction involving Class A Ordinary Shares. Lin acquired 72,720 shares of Class A Ordinary Share, par value US$0.0001, with a transaction price of $0.00 per share. This acquisition increases Lin's post-transaction shares to 1,192,215. Additionally, Lin was granted 72,720 R...

On July 17, 2026, Stacy Lindborg, President and CEO of Imunon, Inc. (IMNN), acquired 4,907 shares of common stock, valued at $1.83 per share, in lieu of cash for a portion of her base salary. This transaction brings her post-transaction holdings to 81,629 shares. Additionally, Lindborg holds 778 shares indirectly throu...

This Form 4 filing reports stock transactions by David S. Marberger, EVP and CFO of Conagra Brands, between July 17-19, 2026. The filing details the vesting of multiple restricted stock unit (RSU) grants and subsequent stock transactions. On July 17, 2026, 16,676 RSUs from a July 2025 grant vested, resulting in acquisi...

Joyce J. Mason, EVP and Corporate Secretary of IDT Corp, reported a sale of 3,488 shares of Class B Common Stock at $62.556 per share and 505 shares at $62.5766 per share on July 17, 2026. Following these transactions, Mason directly owns 35,441 shares and indirectly owns 12,522 shares through a 401(k) plan. The filing...

This filing details a Form 4 submission by Connie Matsui, a director at ARTELO BIOSCIENCES, INC. (ARTL). On July 17, 2026, Matsui acquired 136 shares of Common Stock through the exercise of a stock option. The option, with an exercise price of $1.15, was granted with a vesting commencement date of July 17, 2026. The sh...

This Form 4 filing details a transaction by Robert N. McFarland, a director at ASTROTECH Corp. On July 9, 2026, McFarland acquired 1055 shares of Common Stock through a restricted stock grant under the Astrotech Corporation 2021 Omnibus Equity Incentive Plan. These shares vested immediately on the grant date. The trans...

This filing details a transaction by Saba Capital Management, L.P., a ten percent owner of MEXICO FUND INC (MXF). On July 20, 2026, Saba Capital Management acquired 7,631 shares of Common Stock at a price of $21.49 per share. Following this transaction, the total post-transaction shares owned by Saba Capital Management...

Walter Siegel, SVP, Gen Counsel & Corp Sec of MSC INDUSTRIAL DIRECT CO INC, was granted 2,013 Restricted Stock Units (RSUs) on July 20, 2026. These RSUs are convertible into shares of Class A Common Stock. The RSUs vest in stages between July 20, 2027, and July 20, 2030, contingent upon continued employment. The vested...

This Form 4 filing reports equity transactions by Thomas M. McGough, EVP & COO of Conagra Brands Inc. The filing covers restricted stock unit (RSU) vesting events on July 17 and 19, 2026. On July 17, 16,676 RSUs granted in 2025 vested (33.33% of the grant), resulting in acquisition of 16,676 common shares at $0.00 per ...

Kristian Reich, Chief Scientific Officer of MoonLake Immunotherapeutics (MLTX), reported the sale of 43,700 Class A ordinary shares on July 20, 2026. The shares were sold at a weighted average price of $20.09 per share, with individual sales ranging from $20.00 to $20.25. This transaction was executed under a Rule 10b5...

Saba Capital Management, L.P., a 10% owner of The New Germany Fund, Inc. (NYSE: GF), filed a Form 4 disclosing the purchase of 22,681 shares of common stock on July 20, 2026. The transaction was executed at a price of $11.41 per share, representing an investment of approximately $258,000. Following this purchase, Saba ...

This Form 4 filing reports stock transactions by Melissa C. Napier, SVP and Corporate Controller of Conagra Brands Inc. On July 17, 2026, 3,940 restricted stock units granted in 2025 vested and converted to common shares, with 1,746 shares withheld for taxes at $14.28 per share. On July 19, 2026, 2,388 restricted stock...

Janice Elizabeth Nevin, a director at Cross Country Healthcare, Inc. (CCRN), has reported the sale of 48,616 shares of common stock on July 21, 2026. The transaction, coded as a disposition (D), occurred at a price of $13.25 per share, resulting in zero shares remaining post-transaction. This sale is in connection with...

This filing details a transaction by Nicolelli Maurizio, Executive Vice President & CFO of ExlService Holdings, Inc. On June 30, 2026, Mr. Maurizio acquired 606 shares of common stock at a price of $23.27 per share. This acquisition was made under the ExlService Holdings, Inc. 2022 Employee Stock Purchase Plan, and is ...

This filing details transactions by Nighan Warren JR, SVP Quality and Regulatory at Angiodynamics Inc. On July 16, 2026, 2,153 shares of common stock were disposed of with a price per share of $14.14, leaving 67,750 shares. This disposition was to satisfy tax withholding obligations related to the vesting of restricted...

Javier Rojas Sanchez, a director at Nomadar Corp. (NOMA), reported the acquisition of stock options on July 19, 2026. The transactions include an option for 40,000 shares of Common Stock with an exercise price of $10.00, vesting monthly over two years from his appointment as director. Additionally, two grants of 30,000...

Matthew Coley, Chief Human Resources Officer at Builders FirstSource, Inc., acquired 7,406 restricted stock units on July 18, 2026. These units were granted under the company's 2026 Incentive Plan and vest in three equal increments on July 18 of 2027, 2028, and 2029. Each vested unit entitles the holder to one share of...

This Form 4 filing reports stock transactions by Noelle O'Mara, EVP & President of R&F at Conagra Brands, on July 17, 2026. The filing shows three key transactions: 1) 12,007 restricted stock units (RSUs) vested and converted to common stock at $0 per share, 2) acquisition of 12,007 shares of common stock from the RSU ...

Robert L. Schrader, Sr. VP, CFO of PAYCHEX INC, reported a disposition of 2,600 shares of Common Stock on July 20, 2026. The transaction was executed at a price of $115.09 per share, resulting in a post-transaction ownership of 18,547 shares. Schrader also holds 339 shares of Common Stock through a 401(k) plan. The fil...

Equitable Holdings, Inc. (EQH) CEO Mark Pearson filed a Form 4 disclosing significant stock transactions on July 20, 2026. Pearson exercised 27,200 employee stock options at $23.18 per share, receiving the shares and then immediately sold them as part of a Rule 10b5-1 trading plan adopted in May 2025. Additionally, he ...

Vanessa Allen, EVP, GC and Secretary of Phillips 66 (PSX), reported the sale of 563 shares of Common Stock on July 20, 2026, automatically pursuant to a Rule 10b5-1 trading plan. The weighted average sale price was $211.0082, with individual transactions ranging from $211.00 to $211.03. Following this transaction, Alle...

This Form 4 filing reports that Laura Piccinini, SVP International of AngioDynamics Inc., sold shares of common stock to satisfy tax withholding obligations related to the vesting of restricted stock units. On July 16, 2026, she sold 4,538 shares at $14.14 per share, reducing her holdings to 62,218 shares. On July 17, ...

Shachar Erez, a director at RISKIFIED LTD., reported the sale of 78,800 Class A Ordinary Shares on July 16, 2026, and 7,909 Class A Ordinary Shares on July 17, 2026. These transactions were executed under a Rule 10b5-1 trading plan. The sales occurred at weighted average prices of $5.112 and $5.1888, respectively, with...